🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Molecular Insights Into Post-Cardiac Arrest Brain Injury Via CSF Multi-Omics

Recruitingn/aAges 18 Years - anyAllChungnam National University Hospital
NCT07481396 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this study is to uncover the molecular mechanisms responsible for secondary brain injury in patients with post-cardiac arrest syndrome by analyzing cerebrospinal fluid (CSF) using multi-omics techniques. The main question this study aims to answer is: Which genome-, transcriptome-, proteome-, and metabolome-level changes in CSF are associated with secondary brain injury after cardiac arrest? To address this question, CSF samples collected from post-cardiac arrest patients will undergo multi-omics analyses. Identified molecular pathways will be used to screen existing drug databases and generate new therapeutic candidates through computational modeling and compound synthesis. These findings will provide the scientific foundation needed to design and implement future preclinical experiments using cardiac arrest animal models.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients receiving post-resuscitation care after out-of-hospital cardiac arrest for secondary brain injury treatment. * Patients without contraindications for lumbar puncture catheter insertion for cerebrospinal fluid (CSF) collection. This includes the absence of: * Uncontrolled diabetes.Coagulation disorders. * Thrombocytopenia (platelet count $\< 100,000). * A history of cirrhosis diagnosis. * Current receipt of low molecular weight heparin. * Current use of platelet inhibitors. * A history of posterior spinal fusion that may interfere with catheter insertion. * Local skin infection or rash at the puncture site. * Signs of systemic infection or sepsis. * A history of lumbar puncture within the past 6 hours. Exclusion Criteria: * Cerebral Edema: Patients with evidence of cerebral edema on a brain computed tomography (CT) scan performed immediately after spontaneous circulation recovery. * Patients who underwent extracorporeal membrane oxygenation (ECMO). * Patients who could not maintain integrated therapy for more than 24 hours after cardiac arrest. * Patients with a history of acute or chronic brain disease.
💊

What it tests

  • Not listed
📍

Where

1 site
Chungnam National University Hospital
Daejeon, South Korea
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy